Determinants and rates of retention in HIV care among adolescents receiving antiretroviral therapy in Windhoek, Namibia: a baseline cohort analysis
23 February 2024
Nobel Symposia Series outreach seminar, “Long-term impacts of cash transfer programmes”
11 March 2024
Barriers and facilitators of and strategies for successful community engagement in infectious disease clinical trials in low- and middle- income countries
By: Bey-Marrié Schmidt, Carmen Späth, Myrna van Pinxteren, Primus Che Chi, Charles S Wiysonge, Joy Oliver, Christopher James Colvin
Systematic reviews focusing on community engagement in clinical trials conducted over the past decade have not identified and synthesised barriers, facilitators, and strategies for successful community engagement, specifically in infectious disease clinical trials, LMIC settings, or both.
This publication is a protocol for a Cochrane Review (qualitative). The objectives are as follows:
- To identify and synthesise barriers and facilitators of successful community engagement in infectious disease clinical trials (e.g. HIV, tuberculosis, and malaria) in low‐ and middle‐income countries; and
- To identify and synthesise strategies for engaging community stakeholders in infectious disease clinical trials in low‐ and middle‐income countries.
.
